Bristol-Myers to
stop new
antiviral drug research
(Reuters) -
Bristol-Myers Squibb said on Thursday that it would
stop efforts to find new
antiviral ***** and cut 100 related jobs. The company said it will also discontinue its Hepatitis B and HIV early programs.